Efficacy of Tocilizumab and Baricitinib Combination Therapy in Treatment of Moderate to Severe Covid-19 in Hospitalized Patients
Latest Information Update: 23 Jun 2021
At a glance
- Drugs Baricitinib (Primary) ; Tocilizumab (Primary)
- Indications COVID-19 pneumonia
- Focus Therapeutic Use
- 23 Jun 2021 New trial record
- 05 Jun 2021 Results presented at the 22nd Annual Congress of the European League Against Rheumatism